Ysios Capital — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

TiGenixtakeda.com in 𝕏Nov 2017Acquired

Takeda is a global pharmaceutical company that develops medicines and treatments for patients, focused on advancing science, technology, and partnerships to create new standards of care.

BiotechHealthtechTokyo, JP

Claudia D'Augusta(Executive Officer)Eduardo Bravo Fernandez de Araoz(Executive Officer, Director)Marie Paule Richard(Executive Officer)Wilfried Dalemans(Executive Officer)

BoardJune Almenoff(Director)Russell Greig(Director)

Co-investorsKleiner Perkins Rho Ventures Kreos Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.